Testing effectiveness (Phase 2)Active Not RecruitingNCT06524466
What this trial is testing
Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma
Who this might be right for
Resectable Hepatocellular CarcinomaMacrovascular InvasionCNLC IIIA Stage
Sun Yat-sen University 35